Breast Reduction Surgery and Gynecomastia Surgery | AETNA Coverage Update

Aetna modified CPB 0017 covering breast reduction surgery and gynecomastia surgery, effective March 14, 2026. Here's what billing teams need to do.

Aetna, a CVS Health company, updated its Clinical Policy Bulletin 0017 governing breast reduction and gynecomastia surgery coverage. This Aetna breast reduction surgery coverage policy sets the medical necessity criteria your team must meet to get these procedures covered — and the bar has always been high. The policy update takes effect March 14, 2026. No specific CPT or HCPCS codes are listed in the available policy data for this update, so we'll walk through the clinical and billing framework you need to know.

Quick-Reference Table

Aetna Breast Reduction and Gynecomastia Coverage Criteria and Medical Necessity Requirements 2026

CPB 0017 in the Aetna system is one of the more scrutinized surgical policies in plastics and reconstructive billing. These procedures sit at the intersection of cosmetic and medically necessary surgery — and Aetna draws that line with specific criteria. Get it wrong, and you're looking at a claim denial before the claim even hits adjudication.

For breast reduction surgery (reduction mammaplasty), Aetna's medical necessity criteria have historically required documented physical symptoms caused by breast hypertrophy. Think chronic back pain, shoulder grooving from bra straps, skin rashes or intertrigo beneath the breast, and nerve pain — all tied directly to breast size. Documentation from the treating physician must establish that conservative measures (physical therapy, weight loss, proper bra fitting) failed or are inappropriate.

Aetna also typically requires a minimum tissue resection threshold. The Schnur scale or a similar body-surface-area-adjusted formula determines the minimum grams of breast tissue per side that must be removed for the procedure to qualify as medically necessary rather than cosmetic. If your surgeon's operative plan doesn't address expected resection weight relative to the patient's body surface area, prior authorization is unlikely to go through.

For gynecomastia surgery, the coverage policy distinguishes between true gynecomastia — glandular breast tissue proliferation in males — and pseudogynecomastia, which is fatty tissue accumulation without true glandular involvement. Aetna covers the former under specific conditions. It does not cover the latter. That distinction drives a significant share of claim denials for these procedures, and it needs to be airtight in your documentation before you submit.

Prior authorization is required for both procedures under this coverage policy. Do not schedule these cases without confirmed prior auth. Aetna's prior authorization requirements for breast reduction and gynecomastia surgery include clinical notes, photographs, documentation of conservative treatment failure, and often a letter of medical necessity from the treating provider.

Aetna Breast Reduction and Gynecomastia Surgery Exclusions and Non-Covered Indications

Aetna does not cover breast reduction or gynecomastia surgery when the primary indication is cosmetic. That seems obvious, but the line blurs in practice — especially when patients present with mild symptoms that could be attributed to body image concerns as much as physical pathology.

Procedures performed solely to improve appearance, symmetry, or patient satisfaction without documented functional impairment are excluded. Gynecomastia surgery for pseudogynecomastia — again, fatty tissue without true glandular proliferation — is not covered. Neither is surgery for gynecomastia that is transient, physiologic (as in adolescent gynecomastia that resolves naturally), or asymptomatic.

Breast reduction for patients who haven't attempted conservative measures is also excluded unless contraindications to those measures are documented. If your notes don't address why weight loss or physical therapy was not pursued, expect a denial. Aetna treats that absence of documentation as a missing criterion, not a minor oversight.

The policy also excludes procedures classified as experimental or investigational. Any technique or approach that falls outside the established surgical evidence base for these procedures won't get covered — and you won't win that appeal without peer-reviewed clinical data backing the method.

Coverage Indications at a Glance

Aetna Breast Reduction and Gynecomastia Surgery Billing Guidelines and Action Items 2026

This policy change lands March 14, 2026. If you're billing plastic surgery, reconstructive surgery, or general surgery cases involving these procedures for Aetna members, here's what to do right now.

CPT, HCPCS, and ICD-10 Codes for Breast Reduction and Gynecomastia Surgery Under CPB 0017

The available policy data for this update does not list specific CPT, HCPCS, or ICD-10 codes. This is a known gap in the source data — not an omission on our part.

For breast reduction and gynecomastia billing, the commonly associated procedure codes in standard practice include reduction mammaplasty and gynecomastia excision codes. But we will not publish codes here that aren't confirmed in the actual policy document. Publishing unconfirmed codes creates real financial risk for your team.

What to do: Pull the full CPB 0017 document directly from Aetna's provider portal or from the source policy page. Cross-reference the procedure codes your surgeons use against the specific codes Aetna associates with covered and non-covered indications in the updated bulletin. Then verify those codes in your charge capture before March 14, 2026.

If you're unsure which codes Aetna is adjudicating under this policy, call Aetna provider services and ask them to confirm the applicable CPT codes for CPB 0017. Document that conversation. It matters if you need to appeal.